Natera (NASDAQ:NTRA) Price Target Lowered to $160.00 at Barclays
Natera (NASDAQ:NTRA – Get Free Report) had its target price dropped by Barclays from $200.00 to $160.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target would indicate a potential upside of 8.08% from the company’s previous close. NTRA […]
Natera (NASDAQ:NTRA – Get Free Report) had its target price dropped by Barclays from $200.00 to $160.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the medical research company’s stock. Barclays‘s price target would indicate a potential upside of 8.08% from the company’s previous close. NTRA […]